|Articles|July 31, 2008
PharmTech Poll Results: Outsourced or In-house?
View the results of our poll on what services companies who outsource usually decide to keep in-house.
Advertisement
The question:
If your company uses contract service providers and manufacturers, which function(s) do you typically keep in-house?
Your responses:
- Discovery research (1 response)
- Preclinical animal research
- ADME-tox work
- Formulation development (1 response)
- Process development (1 response)
- Clincial-scale manufacturing through Phase I
- Clinical-scale manufacturing through Phase II
- Clinical-scale manufacturing through Phase III
- Clinical trials
- Scale-up to commercial manufacturing (2 responses)
- Commercial-scale manufacturing (2 responses)
- Fill-finish
- Other
Do you have any comments on this poll, or would you like to submit your vote? Email us at
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5
